| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 08/08/2007 | EP1456382B1 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
| 08/08/2007 | EP1187852B1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS |
| 08/08/2007 | EP0882065B1 Novel human metabotropic glutamate receptor |
| 08/08/2007 | EP0807173B1 Methods for producing immunoglobulins containing protection proteins in plants and their use |
| 08/08/2007 | CN1330669C Recombinant targeted infuse protein for promoting thrombocytopoiesis and its preparation method |
| 08/08/2007 | CN1330664C Expression technology for proteins containing hybrid isotype antibody moiety |
| 08/08/2007 | CN101014626A Glycosylated immunoglobulin and immunoadhesin comprising the same |
| 08/08/2007 | CN101014362A Human complement c3 derivatives with cobra venom factor-like function |
| 08/08/2007 | CN101012458A Expression system |
| 08/08/2007 | CN101012282A Manual transcription factor and highly effective expression method in CHO cell of promotion exogenesis gene thereof |
| 08/08/2007 | CN101012281A Recombination expression and application of blood sugar reducing peptide and human albumin |
| 08/07/2007 | US7253341 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 08/07/2007 | US7253264 Polypeptide for use in the diagnosis and treatment of blood, kidney and liver disoders |
| 08/07/2007 | US7253257 Human metabotropic glutamate receptor subtype mGluR7b |
| 08/07/2007 | US7252998 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 08/07/2007 | US7252997 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 08/07/2007 | US7252825 MAGE-3 peptides presented by HLA class II molecules |
| 08/07/2007 | CA2407952C Growth factor modified protein matrices for tissue engineering |
| 08/07/2007 | CA2381770C Human ctla-4 antibodies and their uses |
| 08/07/2007 | CA2376379C Modified chimeric polypeptides with improved pharmacokinetic properties |
| 08/07/2007 | CA2373252C Long lasting anti-angiogenic peptides |
| 08/02/2007 | WO2007086619A1 Modified glycoprotein having unsaturated functional group |
| 08/02/2007 | WO2007085084A1 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 08/02/2007 | WO2007054717A3 STAUROSPORINE DERIVATIVES FOR THE TREATMENT OF LEUKEMIA CHARACTERISED BY A SPTBNl -FLT3 MUTATION |
| 08/02/2007 | WO2007042326A3 Neisseria meningitidis antigens |
| 08/02/2007 | WO2006099160A3 Bioluminescence resonance energy transfer (bret) systems and methods of use thereof |
| 08/02/2007 | US20070178560 Measuring the energy transfer between fusion proteins comprising a leptin receptor and an energy donor protein ; bone disorders |
| 08/02/2007 | US20070178509 kit for the diagnosis or detection of cancer in a mammal; biomarkers for distinguishing between tumors of differing metastatic potential |
| 08/02/2007 | US20070178492 Human tumor necrosis factor receptor polynucleotides |
| 08/02/2007 | US20070178109 glycoprotein 120; fusion proteins; myelin basic protein; autoimmune diseases; genetic vaccines |
| 08/02/2007 | US20070178105 FHIT proteins and nucleic acids and methods based thereon |
| 08/02/2007 | US20070178094 Autoimmune diseases; antitumor agents; antiallergens; enhancing the immune response of an individual to a specific molecule, by enhancing the MHC class II presentation of an antigenic epitope of the molecule to T lymphocytes of the individual |
| 08/02/2007 | CA2650072A1 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 08/02/2007 | CA2636867A1 Vaccines and immunotherapeutics using codon optimized il-15 and methods for using the same |
| 08/01/2007 | EP1813626A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof, antigens recognized thereby and cells obtained thereby |
| 08/01/2007 | EP1812574A2 Soluble bifunctional proteins |
| 08/01/2007 | EP1745078A4 Method for the purification of albumin conjugates |
| 08/01/2007 | EP1294401B1 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 08/01/2007 | CN1329516C Modification of polysaccharide containing materials |
| 08/01/2007 | CN1329082C Polymer conjugates of interferon beta-1a and their uses |
| 08/01/2007 | CN101008013A pET15b-PEP-1-SOD1 plasmid and its construction, PEP-1-SOD1 fusion protein and its expression |
| 08/01/2007 | CN101008012A Novel human-derived neurotrophic factor BDNF expression structure and its expression |
| 08/01/2007 | CN101007852A Natural antibacterial agent-recombinant chicken-beta defensins Gal-9-Gal-8 double-molecule protein preparation method |
| 07/31/2007 | US7250503 Nucleic acid molecules encoding clot-specific streptokinase fusion proteins possessing altered plasminogen activation characteristics |
| 07/31/2007 | US7250492 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 07/31/2007 | US7250279 Human pyruvate dehydrogenese phosphatase |
| 07/31/2007 | US7250256 Its expression products can be used to provide reagents and methods for detecting neoplasia |
| 07/31/2007 | US7250250 Comprises nucleotide sequences coding proteins with plenty of SH3 domains (POSH) for preventing viral and bacterial infection and replication; rational drug design; viricides; antiapoptosis agents; bactericides |
| 07/31/2007 | US7250168 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome |
| 07/31/2007 | US7250161 Equine GM-CSF |
| 07/31/2007 | CA2085469C Water-soluble polypeptides with strong affinity for .alpha. and .beta. interferons |
| 07/26/2007 | WO2007084021A2 Compositions and methods for diagnosing hiv-2 infection |
| 07/26/2007 | WO2002038600A9 C. elegans genes involved in viability and/or reproduction and uses thereof |
| 07/26/2007 | US20070174922 Nucleic acid encoding novel type-1 cytokine receptor glm-r |
| 07/26/2007 | US20070172516 Increasing of the resorption of substances via skin and mucous membranes |
| 07/26/2007 | US20070172458 IL-6/IL-6R fusion protein |
| 07/25/2007 | EP1811033A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 07/25/2007 | EP1350105B1 Immunoassays for anti-hcv antibodies |
| 07/25/2007 | EP1283875B1 Improved nucleic acid modifying enzymes |
| 07/25/2007 | EP1200594B1 Protective antigen of epstein barr virus |
| 07/25/2007 | CN1328381C GnRH-leukotoxin chimeras |
| 07/25/2007 | CN101003832A Signal system and elements used therein |
| 07/25/2007 | CN101003812A Method in use for preparing recombined EGF-IL18 fusion protein of human |
| 07/25/2007 | CN101003575A Fusion protein in soluble receptor II - antibody Fc section of human tumor necrosis factor |
| 07/25/2007 | CN101003574A Recombined expression of peptide for lowering blood sugar in long acting, and application in medication for treating diabetes |
| 07/25/2007 | CN101003568A Recombined diphtheria toxin, preparation method, and application |
| 07/24/2007 | US7247712 Complex of hepatitis B virus-specific antigenic peptides associated with heat shock proteins and the application thereof |
| 07/24/2007 | US7247612 novel cell surface molecules of mammals |
| 07/24/2007 | US7247608 FGF homolog polypeptides |
| 07/24/2007 | US7247446 PRO34128 nucleic acids |
| 07/24/2007 | US7247301 Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
| 07/24/2007 | CA2162134C Hepatitis-c virus type 4,5 and 6 |
| 07/23/2007 | CA2637947A1 Production of proteins carrying oligomannose or human-like glycans in yeast and methods of use thereof |
| 07/19/2007 | WO2007080977A1 Preventive or therapeutic agent and method for immune disease |
| 07/19/2007 | WO2007079684A1 A mycobacterium tuberculosis fusion protein and uses thereof |
| 07/19/2007 | WO2007015174A3 Exosome-specific ligands, their preparartion and uses |
| 07/19/2007 | WO2003035847A3 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 07/19/2007 | US20070167365 Compositions and methods for modulating blood-brain barrier transport |
| 07/19/2007 | US20070166796 Il-21 antagonists |
| 07/19/2007 | US20070166746 Human cytokine receptor |
| 07/19/2007 | CA2601803A1 Preventive or therapeutic agent and method for immune disease |
| 07/18/2007 | EP1808489A1 Expression system for Bacillus anthracis PA |
| 07/18/2007 | EP1807157A2 Use of apoptosis inhibiting compounds in degenerative neurological disorders |
| 07/18/2007 | EP1040351B1 C-terminal region of agouti-related transcript (art) protein |
| 07/18/2007 | CN1326882C Carcino-embryonic untigen specific combined peptide and fusion protein with TNF-alpha |
| 07/18/2007 | CN1326879C Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 07/18/2007 | CN1326878C Anti human non-Hodgkin's lymphoma chimeric antibody and its derivative and application |
| 07/18/2007 | CN1326873C Vaccine for the prophylactic or therapeutic immunization against HIV |
| 07/18/2007 | CN100999553A IIR2 analogous protein and its coding gene and application |
| 07/18/2007 | CN100999552A Liver target fusion protein with siRNA guiding effect |
| 07/18/2007 | CN100999551A High efficient expression and purification system of small protein structure field in colibacillus |
| 07/18/2007 | CN100999550A Tubercle branch bacillus fusion protein and application thereof |
| 07/17/2007 | US7244835 Nucleotide sequences coding polypeptide for use in the regulation taste |
| 07/17/2007 | US7244833 Yeast expressed with cell proliferation stimulatory factor; hematological disorders |
| 07/17/2007 | US7244832 host cell tranformed with a nucleic acid encoding an antibody having a composite heavy chain with a variable domain including complementarity determining regions and framework regions comprising human acceptor antibody heavy chain framework region residues |
| 07/17/2007 | US7244826 May have a cytotoxin, a label, a radionuclide, a drug, a liposome, a ligand, or an antibody effector attached to the antibody |
| 07/17/2007 | US7244819 Fusion polypeptides, vaccines and compositions of FKBP chaperones and target polypeptides |
| 07/17/2007 | US7244706 For therapy of bacterial infections |
| 07/17/2007 | US7244615 Producing an antibody comprising complementarity determining regions, heavy and light chains, and non-human donor residues, a variable domain; used for in vivo therapy and diagnosis |
| 07/17/2007 | US7244614 Fusion proteins and assays for molecular binding |